v3.10.0.1

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Aug. 31, 2018	Aug. 31, 2017
Revenues	$ 0	$ 0
Operating Expenses
Research and development	248,933	681,829
Administrative	297,730	142,390
Professional fees	100,386	182,943
Depreciation and amortization	255	255
Operating loss	(647,304)	(1,007,417)
Other income (expense)
Interest income	1	1
Interest expense	(128,810)	(157,561)
Loss before income taxes	(776,113)	(1,164,977)
Provision for income taxes	0	0
Net loss	$ (776,113)	$ (1,164,977)
Weighted average number of common shares outstanding	47,325,387	28,767,582
Loss per common share – basic and diluted	$ (0.02)	$ (0.04)

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

PROTALEX INC 10-Q